Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
J Physiol. 1987 Aug; 389: 69–97.
doi: 10.1113/jphysiol.1987.sp016647
PMCID: PMC1192071
PMID: 2445982

Multiple actions of substance P that regulate the functional properties of acetylcholine receptors of clonal rat PC12 cells.

N D Boyd and S E Leeman
Author information Copyright and License information Disclaimer

Abstract

1. The effects of substance P (SP) on each of the kinetic components of reversible desensitization (measured at 4 degrees C) and also on irreversible deactivation (measured at 22 degrees C) of the nicotinic acetylcholine receptor on PC12 cells were examined by 22Na+ influx measurements of the functional state of the receptor. 2. In the absence of agonists, SP converts the acetylcholine receptors in a time- and concentration-dependent manner, to a state that is not responsive to agonist. Upon removal of the peptide, this effect was reversible and the kinetics of the recovery of the permeability response were analysed to provide further characterization of the non-responsive state. Following exposure of cells to SP (10 microM) for 3 or more min, recovery was by a first-order process (time constant, t1/2 = 2.1 min), the same value, within experimental error, as that observed for recovery measured after the initial rapid phase of agonist-mediated desensitization. 3. In the presence of agonist, SP caused a strong enhancement of both the rate and extent of agonist-mediated desensitization. This effect was observed even at concentrations of peptide which produced only a small extent of desensitization when incubated alone. For 500 microM-carbamylcholine, the equilibrium level of desensitization (approximately 85% loss of the permeability response) was achieved at 4 degrees C in about 20 min by a biphasic process, while in the presence of 1.0 microM-SP, complete (100%) desensitization occurred by a single rapid exponential phase characterized by a t1/2 of 20 s. 4. The concentration of carbamylcholine required to produce half-maximal desensitization at equilibrium, Kdes, was 94 microM and was reduced by 6-fold in the presence of 0.3 microM-SP. 5. A mechanistic model is presented in which the receptor is viewed as existing in a dynamic conformational equilibrium between an activatable state Rc and the initial desensitized state Rd. It is proposed that SP binds preferentially to the Rd state and thus can allosterically (1) stabilize the receptor in the absence of agonist in that state, and (2) enhance, in an even lower concentration range, both the rate and extent of agonist-mediated stabilization of the receptor in the Rd state. 6. The second, slower component of agonist-mediated desensitization is, in contrast, inhibited by SP. This desensitization step appears to involve a covalent modification of the initial desensitized state (Rd) and is dependent on Ca2+. SP may exert this inhibitory effect by limiting the access of Ca2+ to an intracellular site of action.(ABSTRACT TRUNCATED AT 400 WORDS)

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 69
69
icon of scanned page 70
70
icon of scanned page 71
71
icon of scanned page 72
72
icon of scanned page 73
73
icon of scanned page 74
74
icon of scanned page 75
75
icon of scanned page 76
76
icon of scanned page 77
77
icon of scanned page 78
78
icon of scanned page 79
79
icon of scanned page 80
80
icon of scanned page 81
81
icon of scanned page 82
82
icon of scanned page 83
83
icon of scanned page 84
84
icon of scanned page 85
85
icon of scanned page 86
86
icon of scanned page 87
87
icon of scanned page 88
88
icon of scanned page 89
89
icon of scanned page 90
90
icon of scanned page 91
91
icon of scanned page 92
92
icon of scanned page 93
93
icon of scanned page 94
94
icon of scanned page 95
95
icon of scanned page 96
96
icon of scanned page 97
97
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Adams PR. Acetylcholine receptor kinetics. J Membr Biol. 1981 Feb 28;58(3):161–174. [PubMed] [Google Scholar]
  • Adams PR, Brown DA, Jones SW. Substance P inhibits the M-current in bullfrog sympathetic neurones. Br J Pharmacol. 1983 Jun;79(2):330–333. [PMC free article] [PubMed] [Google Scholar]
  • Belcher G, Ryall RW. Substance P and Renshaw cells: a new concept of inhibitory synaptic interactions. J Physiol. 1977 Oct;272(1):105–119. [PMC free article] [PubMed] [Google Scholar]
  • Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. [PubMed] [Google Scholar]
  • Björkroth U, Rosell S, Xu JC, Folkers K. Pharmacological characterization of four related substance P antagonists. Acta Physiol Scand. 1982 Oct;116(2):167–173. [PubMed] [Google Scholar]
  • Boyd ND. Two distinct kinetic phases of desensitization of acetylcholine receptors of clonal rat PC12 cells. J Physiol. 1987 Aug;389:45–67. [PMC free article] [PubMed] [Google Scholar]
  • Boyd ND, Cohen JB. Desensitization of membrane-bound Torpedo acetylcholine receptor by amine noncompetitive antagonists and aliphatic alcohols: studies of [3H]acetylcholine binding and 22Na+ ion fluxes. Biochemistry. 1984 Aug 28;23(18):4023–4033. [PubMed] [Google Scholar]
  • Changeux JP, Devillers-Thiéry A, Chemouilli P. Acetylcholine receptor: an allosteric protein. Science. 1984 Sep 21;225(4668):1335–1345. [PubMed] [Google Scholar]
  • Clapham DE, Neher E. Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J Physiol. 1984 Feb;347:255–277. [PMC free article] [PubMed] [Google Scholar]
  • Dun NJ, Karczmar AG. Actions of substance P on sympathetic neurons. Neuropharmacology. 1979 Feb;18(2):215–218. [PubMed] [Google Scholar]
  • Finer-Moore J, Stroud RM. Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc Natl Acad Sci U S A. 1984 Jan;81(1):155–159. [PMC free article] [PubMed] [Google Scholar]
  • Floor E, Leeman SE. Substance P sulfoxide: separation from substance P by high-pressure liquid chromatography, biological and immunological activities, and chemical reduction. Anal Biochem. 1980 Jan 15;101(2):498–503. [PubMed] [Google Scholar]
  • Heidmann T, Oswald RE, Changeux JP. Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983 Jun 21;22(13):3112–3127. [PubMed] [Google Scholar]
  • Hökfelt T, Elfvin LG, Schultzberg M, Goldstein M, Nilsson G. On the occurrence of substance P-containing fibers in sympathetic ganglia: immunohistochemical evidence. Brain Res. 1977 Aug 19;132(1):29–41. [PubMed] [Google Scholar]
  • Hökfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. Peptidergic neurones. Nature. 1980 Apr 10;284(5756):515–521. [PubMed] [Google Scholar]
  • Jones SW. Muscarinic and peptidergic excitation of bull-frog sympathetic neurones. J Physiol. 1985 Sep;366:63–87. [PMC free article] [PubMed] [Google Scholar]
  • Katayama Y, North RA, Williams JT. The action of substance P on neurons of the myenteric plexus of the guinea-pig small intestine. Proc R Soc Lond B Biol Sci. 1979 Nov 30;206(1163):191–208. [PubMed] [Google Scholar]
  • KATZ B, THESLEFF S. A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol. 1957 Aug 29;138(1):63–80. [PMC free article] [PubMed] [Google Scholar]
  • Konishi S, Otsuka M. Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats. Nature. 1974 Dec 20;252(5485):734–735. [PubMed] [Google Scholar]
  • Krodel EK, Beckman RA, Cohen JB. Identification of a local anesthetic binding site in nicotinic post-synaptic membranes isolated from Torpedo marmorata electric tissue. Mol Pharmacol. 1979 Mar;15(2):294–312. [PubMed] [Google Scholar]
  • Linnoila RI, Diaugustine RP, Hervonen A, Miller RJ. Distribution of [Met5]- and [Leu5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands. Neuroscience. 1980;5(12):2247–2259. [PubMed] [Google Scholar]
  • Livett BG, Kozousek V, Mizobe F, Dean DM. Substance P inhibits nicotinic activation of chromaffin cells. Nature. 1979 Mar 15;278(5701):256–257. [PubMed] [Google Scholar]
  • Maleque MA, Souccar C, Cohen JB, Albuquerque EX. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction. Mol Pharmacol. 1982 Nov;22(3):636–647. [PubMed] [Google Scholar]
  • Matthews MR, Cuello AC. Substance P-immunoreactive peripheral branches of sensory neurons innervate guinea pig sympathetic neurons. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1668–1672. [PMC free article] [PubMed] [Google Scholar]
  • MONOD J, WYMAN J, CHANGEUX JP. ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. J Mol Biol. 1965 May;12:88–118. [PubMed] [Google Scholar]
  • Nowak LM, Macdonald RL. Substance P: ionic basis for depolarizing responses of mouse spinal cord neurons in cell culture. J Neurosci. 1982 Aug;2(8):1119–1128. [PMC free article] [PubMed] [Google Scholar]
  • Patrick J, Stallcup B. alpha-Bungarotoxin binding and cholinergic receptor function on a rat sympathetic nerve line. J Biol Chem. 1977 Dec 10;252(23):8629–8633. [PubMed] [Google Scholar]
  • Pelletier G, Steinbusch HW, Verhofstad AA. Immunoreactive substance P and serotonin present in the same dense-core vesicles. Nature. 1981 Sep 3;293(5827):71–72. [PubMed] [Google Scholar]
  • Pernow B. Substance P. Pharmacol Rev. 1983 Jun;35(2):85–141. [PubMed] [Google Scholar]
  • Pfister C, Görne RC. Substanz-P-Immunofluorescenz im Nebennierenmark der Ratte. Acta Histochem. 1983;72(1):127–129. [PubMed] [Google Scholar]
  • Role LW. Substance P modulation of acetylcholine-induced currents in embryonic chicken sympathetic and ciliary ganglion neurons. Proc Natl Acad Sci U S A. 1984 May;81(9):2924–2928. [PMC free article] [PubMed] [Google Scholar]
  • Saria A, Wilson SP, Molnar A, Viveros OH, Lembeck F. Substance P and opiate-like peptides in human adrenal medulla. Neurosci Lett. 1980 Nov;20(2):195–200. [PubMed] [Google Scholar]
  • Sine S, Taylor P. Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells. J Biol Chem. 1979 May 10;254(9):3315–3325. [PubMed] [Google Scholar]
  • Stallcup WB. Sodium and calcium fluxes in a clonal nerve cell line. J Physiol. 1979 Jan;286:525–540. [PMC free article] [PubMed] [Google Scholar]
  • Stallcup WB, Patrick J. Substance P enhances cholinergic receptor desensitization in a clonal nerve cell line. Proc Natl Acad Sci U S A. 1980 Jan;77(1):634–638. [PMC free article] [PubMed] [Google Scholar]
  • Steinacker A, Highstein SM. Pre- and postsynaptic action of substance P at the Mauther fiber-giant fiber synapse in the hatchetfish. Brain Res. 1976 Sep 10;114(1):128–133. [PubMed] [Google Scholar]
Articles from The Journal of Physiology are provided here courtesy of The Physiological Society